S100A9 and Alzheimer disease: In this study, we have focused on the involvement in PD pathology of the specific pro-inflammatory mediator S100A9, which we have found to play a critical role in connecting neuroinflammatory and amyloid pathologies into the integrated amyloid-neuroinflammatory cascade in Alzheimer’s disease [18].